Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary McGowan

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Clinical Lipidology|December 3, 2010
NLA Symposium screening and treatment of familial hypercholesterolemia: how can we do better? Opening and introductionsMary McGowan
Expert Opinion on Investigational Drugs|January 10, 2017
Evaluating bempedoic acid for the treatment of hyperlipidaemiaPeter Penson, Mary McGowan, Maciej Banach
Journal of Clinical Lipidology|December 3, 2010
NLA symposium on familial hypercholesterolemia. Question-and-answer sessionMary McGowan, Defesche, Tom Whayne, et al.
Journal of Managed Care & Specialty Pharmacy|October 29, 2020
Patient-reported dermatomyositis and polymyositis flare symptoms are associated with disability, productivity loss, and health care resource useLisa Christopher-Stine, George J Wan, William Kelly, et al.
Rheumatology and Therapy|March 26, 2026
Outdated Frameworks, Missed Opportunities: A Call for Establishing Classification Criteria for Patients with SarcoidosisNadera J Sweiss, Arnaud Dominati, Mary McGowan, et al.
Circulation|October 13, 2012
Apolipoprotein B synthesis inhibition with mipomersen in heterozygous familial hypercholesterolemia: results of a randomized, double-blind, placebo-controlled trial to assess efficacy and safety as add-on therapy in patients with coronary artery diseaseEvan A Stein, Robert Dufour, Claude Gagne, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Clinical Lipidology|December 3, 2010
NLA Symposium screening and treatment of familial hypercholesterolemia: how can we do better? Opening and introductionsMary McGowan
Expert Opinion on Investigational Drugs|January 10, 2017
Evaluating bempedoic acid for the treatment of hyperlipidaemiaPeter Penson, Mary McGowan, Maciej Banach
Journal of Clinical Lipidology|December 3, 2010
NLA symposium on familial hypercholesterolemia. Question-and-answer sessionMary McGowan, Defesche, Tom Whayne, et al.
Journal of Managed Care & Specialty Pharmacy|October 29, 2020
Patient-reported dermatomyositis and polymyositis flare symptoms are associated with disability, productivity loss, and health care resource useLisa Christopher-Stine, George J Wan, William Kelly, et al.
Rheumatology and Therapy|March 26, 2026
Outdated Frameworks, Missed Opportunities: A Call for Establishing Classification Criteria for Patients with SarcoidosisNadera J Sweiss, Arnaud Dominati, Mary McGowan, et al.
Circulation|October 13, 2012
Apolipoprotein B synthesis inhibition with mipomersen in heterozygous familial hypercholesterolemia: results of a randomized, double-blind, placebo-controlled trial to assess efficacy and safety as add-on therapy in patients with coronary artery diseaseEvan A Stein, Robert Dufour, Claude Gagne, et al.
Pageof 1